Whipplewood Advisors LLC Sells 218 Shares of Intuitive Surgical, Inc. $ISRG

Whipplewood Advisors LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 41.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 310 shares of the medical equipment provider’s stock after selling 218 shares during the quarter. Whipplewood Advisors LLC’s holdings in Intuitive Surgical were worth $168,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Norway Savings Bank boosted its stake in Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after purchasing an additional 910 shares during the period. IronOak Wealth LLC. bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $1,099,000. Trust Co. of Oklahoma bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $363,000. Neville Rodie & Shaw Inc. boosted its position in shares of Intuitive Surgical by 11.9% during the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares during the last quarter. Finally, Sax Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 218.1% during the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after acquiring an additional 1,684 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $546.51 on Monday. The business has a 50 day moving average of $458.09 and a 200 day moving average of $497.11. The company has a market capitalization of $195.91 billion, a price-to-earnings ratio of 72.29, a PEG ratio of 5.02 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ISRG. Royal Bank Of Canada set a $625.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Sunday. Wells Fargo & Company lifted their price target on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Finally, Jefferies Financial Group lifted their price target on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $602.32.

Insider Buying and Selling

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the transaction, the director directly owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,031 shares of company stock valued at $14,177,895 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.